Seaport Therapeutics (SPTX) IPO deck
Seaport Therapeutics is a clinical-stage biotechnology company developing innovative oral therapies for neuropsychiatric disorders such as depression and anxiety.
Seaport Therapeutics is a clinical-stage biotechnology company developing innovative oral therapies for neuropsychiatric disorders such as depression and anxiety.
%20IPO%20deck){kind=link}